CompareOpen in Google Play
This app isn't in any of our charts yet.
Initial release
This app is specifically intended for participants in the GSK 221458 study only
This app is specifically intended for participants in the GSK 221458 study only. It contains Televisit functionality and allows participants to complete questionnaires. The study is a Phase 1, first-time-in-human, three-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active systemic lupus erythematosus (Part B), and healthy participants of Chinese and Japanese descent (Part C). (Televisit tasks are not enabled by default and may be enabled as needed, by study officials.)
Not enough data yet.
Google Play only. Downloads from daily Top free ranks (or the store's install count); in-app revenue from Top grossing ranks, calibrated on AppTweak's US estimates, or else from downloads; ads from public ad benchmarks. Not reported figures.